Furthermore, survival analysis of each significant PID-related DEG determined that C1R, RPL5, and TERT may be indicative of patient prognosis when differentially expressed and should be studied further to better understand how treatment alterations regarding these genes may improve patient outcomes. This evidence concerns the gene C1R and pelvic inflammatory disease.